These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9990183)
1. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. Farley TA; Niccolai LM; Billeter M; Kissinger PJ; Grace M J Am Pharm Assoc (Wash); 1999; 39(1):23-6. PubMed ID: 9990183 [TBL] [Abstract][Full Text] [Related]
2. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. Wright-De Agüero L; Weinstein B; Jones TS; Miles J J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632 [TBL] [Abstract][Full Text] [Related]
3. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. Gleghorn AA; Gee G; Vlahov D J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630 [TBL] [Abstract][Full Text] [Related]
4. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley. Pollini RA J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658 [TBL] [Abstract][Full Text] [Related]
5. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Coffin PO; Linas BP; Factor SH; Vlahov D J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317 [TBL] [Abstract][Full Text] [Related]
6. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. Case P; Beckett GA; Jones TS J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631 [TBL] [Abstract][Full Text] [Related]
7. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. Rich JD; Martin EG; Macalino GE; Paul RV; McNamara S; Taylor LE J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S58-61. PubMed ID: 12489617 [TBL] [Abstract][Full Text] [Related]
8. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Lewis BA; Koester SK; Bush TW J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615 [TBL] [Abstract][Full Text] [Related]
9. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. Linas BP; Coffin PO; Backes G; Vlahov D J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316 [TBL] [Abstract][Full Text] [Related]
10. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. Blumenthal WJ; Springer KW; Jones TS; Sterk CE J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S34-9. PubMed ID: 12489613 [TBL] [Abstract][Full Text] [Related]
11. Pharmacy nonprescription syringe distribution and HIV/AIDS: a review. Janulis P J Am Pharm Assoc (2003); 2012; 52(6):787-97. PubMed ID: 23229966 [TBL] [Abstract][Full Text] [Related]
12. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993. Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288 [TBL] [Abstract][Full Text] [Related]
13. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724 [TBL] [Abstract][Full Text] [Related]
15. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of nonprescription syringe sales in San Francisco. Rose VJ; Raymond HF J Am Pharm Assoc (2003); 2010; 50(5):595-9. PubMed ID: 20833617 [TBL] [Abstract][Full Text] [Related]
17. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon. Ghaddar A; Nassar K; Elsoury G Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013 [TBL] [Abstract][Full Text] [Related]
18. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users. Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM Health Educ Behav; 2014 Aug; 41(4):397-405. PubMed ID: 24722219 [TBL] [Abstract][Full Text] [Related]
19. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621 [TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]